Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Nov;77(11):716–720. doi: 10.1136/bjo.77.11.716

Impairment of colour contrast sensitivity and neuroretinal dysfunction in patients with symptomatic HIV infection or AIDS.

S A Geier 1, U Kronawitter 1, J R Bogner 1, G Hammel 1, T Berninger 1, V Klauss 1, F D Goebel 1
PMCID: PMC504631  PMID: 8280686

Abstract

Ophthalmic and neurological complications are frequent findings in patients with AIDS. Little is known about neuroretinal dysfunction in patients with HIV infection. The purpose of this study was to measure and evaluate colour vision in patients with HIV infection or AIDS. Colour contrast sensitivity tests were performed on 75 patients (150 eyes) in different stages of HIV infection. A highly sensitive computer graphics system was used to measure tritan, deutan, and protan colour contrast thresholds. Patients were classified into three clinical groups: (a) asymptomatic HIV infection, (b) lymphadenopathy syndrome or AIDS-related complex, and (c) AIDS. Overall, tritan (p < 0.0001), deutan (p = 0.003), and protan (p = 0.009) colour contrast sensitivities were significantly impaired in patients with HIV infection compared with normal controls. Colour thresholds in patients with asymptomatic HIV infection (mean tritan threshold: 4.33; deutan: 4.41; protan: 3.97) were not impaired compared with normal controls. Colour vision was slightly impaired in patients with lymphadenopathy syndrome or AIDS-related complex (tritan: 6.25 (p < 0.0001); deutan: 4.99 (p = 0.02); protan: 4.45 (p = 0.05)). In patients with AIDS the impairment was even more marked (tritan: 7.66 (p < 0.0001); deutan: 5.15 (p < 0.0009); protan: 4.63 (p = 0.004)). Analysis of covariance controlling for age demonstrated a close association between impairment of tritan colour contrast sensitivity and progression of HIV disease (p < 0.0001). Following Köllner's rule, our study suggests that neuroretinal dysfunction occurs in patients with symptomatic HIV infection or AIDS. This is emphasised by the finding that the relative impairment in tritan vision compared with deutan/protan vision might reflect the difference in the number of cones or receptive fields. Measurement of tritan colour contrast sensitivity appears to be an appropriate and easily applicable method to detect early neuroretinal dysfunction in patients with HIV disease.

Full text

PDF
716

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abt K. Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Methods Inf Med. 1987 Apr;26(2):77–88. [PubMed] [Google Scholar]
  2. Arden G. B., Berninger T., Hogg C. R., Perry S. A survey of color discrimination in German ophthalmologists. Changes associated with the use of lasers and operating microscopes. Ophthalmology. 1991 May;98(5):567–575. [PubMed] [Google Scholar]
  3. Bresnick G. H., Condit R. S., Palta M., Korth K., Groo A., Syrjala S. Association of hue discrimination loss and diabetic retinopathy. Arch Ophthalmol. 1985 Sep;103(9):1317–1324. doi: 10.1001/archopht.1985.01050090069034. [DOI] [PubMed] [Google Scholar]
  4. Brodie S. E., Friedman A. H. Retinal dysfunction as an initial ophthalmic sign in AIDS. Br J Ophthalmol. 1990 Jan;74(1):49–51. doi: 10.1136/bjo.74.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cantrill H. L., Henry K., Jackson B., Erice A., Ussery F. M., Balfour H. H., Jr Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology. 1988 Oct;95(10):1458–1462. doi: 10.1016/s0161-6420(88)33011-3. [DOI] [PubMed] [Google Scholar]
  6. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  7. Freeman W. R., Chen A., Henderly D. E., Levine A. M., Luttrull J. K., Urrea P. T., Arthur J., Rasheed S., Cohen J. L., Neuberg D. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989 Mar 15;107(3):229–235. doi: 10.1016/0002-9394(89)90304-8. [DOI] [PubMed] [Google Scholar]
  8. Geier S. A., Held M., Bogner J. R., Kronawitter U., Berninger T., Klauss V., Goebel F. D. Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS. Br J Ophthalmol. 1993 May;77(5):315–316. doi: 10.1136/bjo.77.5.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Geier S. A., Holler K., Nasemann J., Bogner J. R., Scheider A., Klauss V., Kronawitter U., Goebel F. D. Retinal microvascular abnormalities in patients with AIDS-related complex or lymphadenopathy syndrome. AIDS. 1993 May;7(5):746–748. [PubMed] [Google Scholar]
  10. Geier S. A., Perro C., Klauss V., Naber D., Kronawitter U., Bogner J. R., Goebel F. D., Lund O. E., Hippius H. HIV-related ocular microangiopathic syndrome and cognitive functioning. J Acquir Immune Defic Syndr. 1993 Mar;6(3):252–258. [PubMed] [Google Scholar]
  11. Geier S. A., Schielke E., Klauss V., Müller A., Einhäupl K. M., Goebel F. D., Tatsch K. Retinal microvasculopathy and reduced cerebral blood flow in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):100–101. doi: 10.1016/s0002-9394(14)75763-0. [DOI] [PubMed] [Google Scholar]
  12. Gouras P., Zrenner E. Enchancement of luminance flicker by color-opponent mechanisms. Science. 1979 Aug 10;205(4406):587–589. doi: 10.1126/science.109925. [DOI] [PubMed] [Google Scholar]
  13. Greenstein V. C., Shapiro A., Zaidi Q., Hood D. C. Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2781–2790. [PubMed] [Google Scholar]
  14. Greenstein V., Sarter B., Hood D., Noble K., Carr R. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1990 Jun;31(6):1008–1014. [PubMed] [Google Scholar]
  15. Gündüz K., Arden G. B. Changes in colour contrast sensitivity associated with operating argon lasers. Br J Ophthalmol. 1989 Apr;73(4):241–246. doi: 10.1136/bjo.73.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Holland G. N., Gottlieb M. S., Yee R. D., Schanker H. M., Pettit T. H. Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol. 1982 Apr;93(4):393–402. doi: 10.1016/0002-9394(82)90127-1. [DOI] [PubMed] [Google Scholar]
  17. Hood D. C., Benimoff N. I., Greenstein V. C. The response range of the blue-cone pathways: a source of vulnerability to disease. Invest Ophthalmol Vis Sci. 1984 Jul;25(7):864–867. [PubMed] [Google Scholar]
  18. Jakobsen J., Smith T., Gaub J., Helweg-Larsen S., Trojaborg W. Progressive neurological dysfunction during latent HIV infection. BMJ. 1989 Jul 22;299(6693):225–228. doi: 10.1136/bmj.299.6693.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Keating J. N., Trimble K. C., Mulcahy F., Scott J. M., Weir D. G. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet. 1991 Apr 20;337(8747):935–939. doi: 10.1016/0140-6736(91)91570-k. [DOI] [PubMed] [Google Scholar]
  20. Koralnik I. J., Beaumanoir A., Häusler R., Kohler A., Safran A. B., Delacoux R., Vibert D., Mayer E., Burkhard P., Nahory A. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990 Sep 27;323(13):864–870. doi: 10.1056/NEJM199009273231303. [DOI] [PubMed] [Google Scholar]
  21. Lantos P. L., McLaughlin J. E., Schoitz C. L., Berry C. L., Tighe J. R. Neuropathology of the brain in HIV infection. Lancet. 1989 Feb 11;1(8633):309–311. doi: 10.1016/s0140-6736(89)91316-0. [DOI] [PubMed] [Google Scholar]
  22. Levy R. M., Bredesen D. E., Rosenblum M. L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985 Apr;62(4):475–495. doi: 10.3171/jns.1985.62.4.0475. [DOI] [PubMed] [Google Scholar]
  23. Mansour A. M. Neuro-ophthalmic findings in acquired immunodeficiency syndrome. J Clin Neuroophthalmol. 1990 Sep;10(3):167–174. [PubMed] [Google Scholar]
  24. Marc R. E., Sperling H. G. Chromatic organization of primate cones. Science. 1977 Apr 22;196(4288):454–456. doi: 10.1126/science.403607. [DOI] [PubMed] [Google Scholar]
  25. Newsome D. A., Green W. R., Miller E. D., Kiessling L. A., Morgan B., Jabs D. A., Polk B. F. Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol. 1984 Nov;98(5):590–601. doi: 10.1016/0002-9394(84)90245-9. [DOI] [PubMed] [Google Scholar]
  26. Pepose J. S., Holland G. N., Nestor M. S., Cochran A. J., Foos R. Y. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985 Apr;92(4):472–484. doi: 10.1016/s0161-6420(85)34008-3. [DOI] [PubMed] [Google Scholar]
  27. Petito C. K., Cho E. S., Lemann W., Navia B. A., Price R. W. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986 Nov;45(6):635–646. doi: 10.1097/00005072-198611000-00003. [DOI] [PubMed] [Google Scholar]
  28. Pocock S. J., Hughes M. D., Lee R. J. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med. 1987 Aug 13;317(7):426–432. doi: 10.1056/NEJM198708133170706. [DOI] [PubMed] [Google Scholar]
  29. Polk B. F., Fox R., Brookmeyer R., Kanchanaraksa S., Kaslow R., Visscher B., Rinaldo C., Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med. 1987 Jan 8;316(2):61–66. doi: 10.1056/NEJM198701083160201. [DOI] [PubMed] [Google Scholar]
  30. Pomerantz R. J., Kuritzkes D. R., de la Monte S. M., Rota T. R., Baker A. S., Albert D., Bor D. H., Feldman E. L., Schooley R. T., Hirsch M. S. Infection of the retina by human immunodeficiency virus type I. N Engl J Med. 1987 Dec 24;317(26):1643–1647. doi: 10.1056/NEJM198712243172607. [DOI] [PubMed] [Google Scholar]
  31. Quiceno J. I., Capparelli E., Sadun A. A., Munguia D., Grant I., Listhaus A., Crapotta J., Lambert B., Freeman W. R. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):8–13. doi: 10.1016/s0002-9394(14)75745-9. [DOI] [PubMed] [Google Scholar]
  32. Redfield R. R., Wright D. C., Tramont E. C. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med. 1986 Jan 9;314(2):131–132. doi: 10.1056/NEJM198601093140232. [DOI] [PubMed] [Google Scholar]
  33. Roy M. S., Gunkel R. D., Podgor M. J. Color vision defects in early diabetic retinopathy. Arch Ophthalmol. 1986 Feb;104(2):225–228. doi: 10.1001/archopht.1986.01050140079024. [DOI] [PubMed] [Google Scholar]
  34. Skolnik P. R., Pomerantz R. J., de la Monte S. M., Lee S. F., Hsiung G. D., Foos R. Y., Cowan G. M., Kosloff B. R., Hirsch M. S., Pepose J. S. Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus. Am J Ophthalmol. 1989 Apr 15;107(4):361–372. doi: 10.1016/0002-9394(89)90659-4. [DOI] [PubMed] [Google Scholar]
  35. Smith R. Diabetes and retinal function. Br J Ophthalmol. 1990 Jul;74(7):385–385. doi: 10.1136/bjo.74.7.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Smith T., Jakobsen J., Gaub J., Helweg-Larsen S., Trojaborg W. Clinical and electrophysiological studies of human immunodeficiency virus-seropositive men without AIDS. Ann Neurol. 1988 Mar;23(3):295–297. doi: 10.1002/ana.410230313. [DOI] [PubMed] [Google Scholar]
  37. Staal F. J., Ela S. W., Roederer M., Anderson M. T., Herzenberg L. A., Herzenberg L. A. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 1992 Apr 11;339(8798):909–912. doi: 10.1016/0140-6736(92)90939-z. [DOI] [PubMed] [Google Scholar]
  38. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. doi: 10.1073/pnas.83.18.7089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. de la Monte S. M., Ho D. D., Schooley R. T., Hirsch M. S., Richardson E. P., Jr Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology. 1987 Apr;37(4):562–569. doi: 10.1212/wnl.37.4.562. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES